REQUEST A DEMO
Total
USD $0.00
Search more companies

TTY Biopharm Company Limited (Taiwan, China)

Main Activities: Professional, Scientific, and Technical Services
Full name: TTY Biopharm Company Limited Profile Updated: November 05, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English & Chinese Download a sample report

Formerly known as Taiwan Tung Yang Chemical Industries Co., Ltd., TTYBiopharm Co.,Ltd. was founded on July 22, 1960. In August 1968 it set up the factory in Chungli, began technical cooperation with TOYOJOZO Co., Ltd. Japan, producing new products developed by TOYOJOZO. In January 1993, it set up a joint venture with Shanghai Xudong Haipu. In October 1997 in merged with Dongxing Drugs (holding) Corporation. In July 1998, Securities & Futures Commission approved its public offering of stock. In January 1999 the new liposome technology was patented co-developed with Taiwan Liposome (Holding) Compan. In April 2000 the first anti-cancer drug UFUR obtained new drug license by Health Department (on No.77 Notice)。 On September 27 2001, its stock went listed in OTC market.

Headquarters
3F., No.3-1, Yuanqu St., Taipei, Taiwan
New Taipei City; New Taipei City;

Contact Details: Purchase the TTY Biopharm Company Limited report to view the information.

Website: http://www.tty.com.tw

Basic Information
Total Employees:
Purchase the TTY Biopharm Company Limited report to view the information.
Outstanding Shares:
Purchase the TTY Biopharm Company Limited report to view the information.
Financial Auditors:
Purchase the TTY Biopharm Company Limited report to view the information.
Ratings:
Purchase the TTY Biopharm Company Limited report to view the information.
Incorporation Date:
July 22, 1960
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
President
Purchase this report to view the information.
Spokesperson
Ownership Details
Purchase this report to view the information.
9.45%
Purchase this report to view the information.
1.77%
Purchase this report to view the information.
0.78%
Purchase this report to view the information.
0.05%
Purchase this report to view the information.
Subsidiaries
Rong Gang International
100%
Xu Dong Hai Pu International (Cayman)
100%
American Taiwan Biopharma Philippines Inc.
87%
Company Performance
Financial values in the chart are available after TTY Biopharm Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
0.63%
Total operating revenue
0.63%
Operating profit (EBIT)
-1.08%
EBITDA
-31.64%
Net Profit (Loss) for the Period
-47.78%
Total assets
1.96%
Total equity
11.95%
Operating Profit Margin (ROS)
-0.43%
Net Profit Margin
-10.67%
Return on Equity (ROE)
-4.24%
Debt to Equity Ratio
7.74%
Quick Ratio
0.52%
Cash Ratio
0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?